Ownership Profile
Ownership Profile
Top Holders
| Holder | Shares Held | % O/S | Share Change | Filing Date |
|---|---|---|---|---|
| Fidelity Management & Research Company LLC | 21,320,886 | 15.04 | 139,384 | 3/31/22 |
| T. Rowe Price Associates, Inc. | 14,350,460 | 10.12 | 1,860,180 | 3/31/22 |
| The Vanguard Group, Inc. | 12,099,034 | 8.53 | 91,958 | 3/31/22 |
| Bellevue Asset Management AG | 9,918,073 | 6.99 | -437,050 | 3/31/22 |
| T. Rowe Price Investment Management, Inc. | 7,819,762 | 5.51 | 118,658 | 6/30/22 |
| BlackRock Institutional Trust Company, N.A. | 7,046,653 | 4.97 | -66,434 | 3/31/22 |
| ClearBridge Investments, LLC | 6,476,033 | 4.57 | 593,051 | 3/31/22 |
| ARK Investment Management LLC | 4,701,297 | 3.32 | -1,470,011 | 6/30/22 |
| State Street Global Advisors (US) | 4,030,646 | 2.84 | 124,271 | 3/31/22 |
| Camber Capital Management LP | 3,000,000 | 2.12 | 1,610,000 | 3/31/22 |
Top Holders: Mutual Funds
| Fund | Shares Held | % O/S | Share Change | Filing Date |
|---|---|---|---|---|
| BB Biotech Fd | 9,732,973 | 6.86 | 620,000 | 3/31/22 |
| Fidelity Growth Company Fund | 7,304,746 | 5.15 | -48,419 | 6/30/22 |
| T. Rowe Price Mid-Cap Growth Fund | 4,242,300 | 2.99 | -6,500 | 6/30/22 |
| ARK Genomic Revolution ETF | 4,191,790 | 2.96 | -317,077 | 6/30/22 |
| Vanguard Total Stock Market Index Fund | 3,544,794 | 2.50 | 24,578 | 6/30/22 |
| Vanguard Small-Cap Index Fund | 3,044,141 | 2.15 | 25,869 | 6/30/22 |
| SPDR S&P Biotech ETF | 2,090,794 | 1.47 | 16,182 | 7/31/22 |
| ClearBridge Aggressive Growth Fund | 2,086,537 | 1.47 | -- | 6/30/22 |
| Fidelity Series Growth Company Fund | 1,970,769 | 1.39 | 60,000 | 6/30/22 |
| Vanguard Extended Market Index Fund | 1,902,852 | 1.34 | 23,191 | 6/30/22 |
* Insider values reflect direct beneficial ownership.
Copyright Refinitiv